[1] Sharrocks, Andrew D. “The ETS-domain transcription factor family.” Nature Reviews Molecular Cell
Biology Vol. 2, No. 11, 2001, pp. 827-37.
[2] Graves, Barbara J., and Jeannine M. Petersen. “Specificity within the ETS family of transcription factors.” Advances
in Cancer Research Vol. 75, 1998, pp. 1-57.
[3] Maroulakou, Ioanna G., and Damon B. Bowe. “Expression and function of ETS transcription factors in mammalian
development: a regulatory network.” Oncogene Vol. 19, No. 55, 2000, p. 6432.
[4] Truong, Amandine HL, and Yaacov Ben-David. “The role of Fli-1 in normal cell function and malignant
transformation.” Oncogene Vol. 19, No. 55, 2000, p. 6482.
[5] Watson, Dennis K., et al. “The ERGB/Fli-1 gene: Isolation and characterization of a new member of the family
of human ETS transcription factors.” Cell Growth and Differentiation Vol. 3, 1992, pp. 705-13.
[6] Ben-David, Yaacov, Elizabeth B. Giddens, and Alan Bernstein. “Identification and mapping of a common
proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus.” Proceedings of
the National Academy of Sciences Vol. 87, No. 4, 1990, pp. 1332-36.
[7] Ben-David, Y., et al. “Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a
new member of the ETS gene family, Fli-1, closely linked to c-ets-1.” Genes & Development Vol. 5, No. 6, 1991,
pp. 908-18.
Inam Jasim Lafta Int J Med Res Health Sci 2017, 6(12): 87-95
95
[8] Selleri, L., et al. “Cloning of the entire FL11 gene, disrupted by the Ewing’s Sarcoma translocation breakpoint on
11q24, in a yeast artificial chromosome.” Cytogenetic and Genome Research Vol. 67, No. 2, 1994, pp. 129-36.
[9] Delattre, Olivier, et al. “Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in
human tumours.” Nature Vol. 359, No. 6391, 1992, pp. 162-65.
[10] Bonin, Gersende, et al. “Chimeric EWS-FL11 Transcript in a Ewing Cell Line with a Complex t (11; 22; 14)
Translocation.” Cancer Research Vol. 53, No. 16, 1993, pp. 3655-57.
[11] Welford, Scott M., et al. “DNA binding domain-independent pathways are involved in EWS/FLI1-mediated
oncogenesis.” Journal of Biological Chemistry Vol. 276, No. 45, 2001, pp. 41977-84.
[12] Sakurai, Takuya, et al. “Functional roles of Fli-1, a member of the Ets family of transcription factors, in human
breast malignancy.” Cancer Science Vol. 98, No. 11, 2007, pp. 1775-84.
[13] Tamir, Ami, et al. “Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid
proliferation and differentiation: Evidence for direct transcriptional repression of the Rb gene during
differentiation.” Molecular and Cellular Biology Vol. 19, No. 6, 1999, pp. 4452-64.
[14] Asano, Yoshihide, and Maria Trojanowska. “Fli1 represses transcription of the human α2 (I) collagen gene by
recruitment of the HDAC1/p300 complex.” PloS one Vol. 8, No. 9, 2013, p. e74930.
[15] Truong, Amandine HL, et al. “Direct transcriptional regulation of MDM2 by Fli-1.” Oncogene Vol. 24, No. 6,
2005, pp. 962-969.
[16] Scheiber, Melissa N., et al. “FLI1 expression is correlated with breast cancer cellular growth, migration, and
invasion and altered gene expression.” Neoplasia Vol. 16, No. 10, 2014, pp. 801-13.
[17] He, Jin, et al. “Profile of ETS gene expression in human breast carcinoma.” Cancer Biology & Therapy Vol. 6,
No. 1, 2007, pp. 76-82.
[18] Zhang, Jianjun, et al. “Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene
friend leukemia virus integration 1 gene.” Cancer Vol. 117, No. 1, 2011, pp. 86-95.
[19] Crossen, Peter E., et al. “Identification of amplified genes in a patient with acute myeloid leukemia and double
minute chromosomes.” Cancer genetics and cytogenetics Vol. 113, No. 2, 1999, pp. 126-33.
[20] Tyybäkinoja, Anne, et al. “Amplified, lost, and fused genes in 11q23–25 amplicon in acute myeloid leukemia,
an array-CGH study.” Genes, Chromosomes and Cancer Vol. 45, No. 3, 2006, pp. 257-64.
[21] Savli, Hakan, Sema Sirma, and Uğur Özbek. “Quantification of the FLI1 gene expression by real-time quantitative
RT-PCR.” Turkish Journal of Medical Sciences Vol. 33, No. 1, 2003, pp. 21-25.
[22] Dhulipala, Prasad DK, et al. “Fli-1b is generated by usage of differential splicing and alternative
promoter.” Oncogene Vol. 17, No. 9, 1998.
[23] Holliday, Deborah L., and Valerie Speirs. “Choosing the right cell line for breast cancer research.” Breast Cancer
Research Vol. 13, No. 4, 2011, p. 215.
[24] Kao, Jessica, et al. “Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a
resource for cancer gene discovery.” PloS one Vol. 4, No. 7, 2009, p. e6146.
[25] Hattori, Tomoyasu, et al. “Fli1 is a negative regulator of estrogen receptor α in dermal fibroblasts.” Journal of
Investigative Dermatology Vol. 131, No. 7, 2011, pp. 1469-76.
Thank you for copying data from http://www.arastirmax.com